Abstract
We discuss tradeoffs and errors associated with alternative approaches to modeling health economic decisions. Through an application in pharmacogenomics (PGx), we assessed model accuracy, optimal decisions and computation time for an identical decision scenario modeled four ways.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
